Induction of IgG antibodies directed to a M(r) 31,000 melanoma antigen in patients immunized with vaccinia virus melanoma oncolysates.
Induction of IgG antibodies directed to a M(r) 31,000 melanoma antigen in patients immunized with vaccinia virus melanoma oncolysates.
复制标题
在用痘苗病毒黑色素瘤溶瘤物免疫的患者中诱导针对 M(r) 31,000 黑色素瘤抗原的 IgG 抗体。
作者：
O. Berthier‐Vergnes;J. Portoukalian;É. Leftheriotis;J. Doré
Pre- and postimmunization sera from eight tumor-free melanoma patients undergoing vaccinia melanoma oncolysate (VMO) therapy were used to investigate the humoral response to antigens from infected and uninfected melanoma cells and from vaccinia virus. Immunodetection on Western blots showed that all patients, in addition to reacting to several other proteins, developed IgG antibodies to a M(r) 31,000 protein antigen within 1 month of immunization. This M(r) 31,000 antigen is expressed both on VMO and on melanoma metastases in situ, disappears in primary cultures of these metastases, and is absent in extracts from vaccinia virus, from human melanoma cell lines, and from normal melanocytes, suggesting that this M(r) 31,000 protein is reexpressed following vaccinia virus infection of human melanoma cells. Periodate treatment of the blotted antigens abolished reactivity of patients' postimmunization sera with the M(r) 31,000 antigen, thus showing that this antigen is a glycoprotein and that the relevant epitope is likely to reside on its carbohydrate moiety. These anti-M(r) 31,000 IgG antibodies were absent in the sera of VMO-treated patients before immunization, absent in the serum of a normal donor hyperimmunized with vaccinia virus, and absent in normal human sera. In addition, these anti-M(r) 31,000 antibodies appeared 1 week after the first VMO injection, remained stable during the treatment, and decreased when the treatment was stopped. Such antibodies can also be demonstrated in sera of melanoma patients bearing metastases but disappeared following resection of their metastases. Thus, in melanoma patients, immunization with VMO induces an antibody response directed against a M(r) 31,000 glycoprotein likely to represent a new melanoma antigen. Further identification of this antigen could be of utmost interest for the further development of melanoma vaccines.
登录
查看更多内容
体外和体内人类肿瘤相关抗原的脱落。
影响因子：
--
作者：
Herlyn,M;Rodeck,U;Koprowski,H
通讯作者：
Koprowski,H
人类黑色素瘤相关抗原。
DOI：
--
发表时间：
1989
期刊：
Immunology series
影响因子：
--
作者：
GrafJr,LH;Ferrone,S
通讯作者：
Ferrone,S
影响因子：
11.2
作者：
M. Herlyn;W. Clark;M. Mastrangelo;D. Guerry;D. Elder;D. Larossa;R. Hamilton;E. Bondi;R. Tuthill;Z. Steplewski;H. Koprowski
通讯作者：
M. Herlyn;W. Clark;M. Mastrangelo;D. Guerry;D. Elder;D. Larossa;R. Hamilton;E. Bondi;R. Tuthill;Z. Steplewski;H. Koprowski
使用高碘酸盐氧化检测碳水化合物表位特异性单克隆抗体。
影响因子：
2.2
作者：
Woodward,MP;YoungJr,WW;Bloodgood,RA
通讯作者：
Bloodgood,RA
干扰素-γ 对不同转移潜能的人黑色素瘤细胞 HLA-DR 表达的影响。
DOI：
10.1111/j.1600-0749.1990.tb00282.x
发表时间：
1990
期刊：
Pigment cell research
影响因子：
--
作者：
Hendrix,MJ;Seftor,EA;Eckes,MD;Winters,AL;Leong,SP;Scuderi,P
通讯作者：
Scuderi,P